Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BPTF | Q12830 | 1/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 10/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 9/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 6/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27366426 | 0.80 | ACACB (0.33) | CHRNA4CHRNB2CHRNB4CHRNA3GPR119 | |
| SCHEMBL22737347 | 0.79 | CHRNA7 (0.43) | CHRNA4CHRNB2CHRNA7CHRNB4CHRNA3 | |
| SCHEMBL27363075 | 0.79 | CHRNA7 (0.43) | CHRNA4CHRNB2CHRNA7CHRNB4CHRNA3 | |
| SCHEMBL29367080 | 0.79 | BPTF (0.52) | BPTFCHRNA4CHRNB2CHRNA7CHRNB4 | |
| SCHEMBL11922742 | 0.77 | CHRNB2 (0.40) | BPTFCHRNA4CHRNB2CHRNA7CHRNB4 | |
| SCHEMBL14845792 | 0.77 | CHRNA7 (0.47) | BPTFCHRNA4CHRNB2CHRNA7GPR119 | |
| SCHEMBL25389142 | 0.77 | ACACB (0.46) | BPTFCHRNA4CHRNB2CHRNA7 | |
| Hydrochloric Acid SCHEMBL29363810 | 0.77 | CHRNA7 (0.53) | BPTFCHRNA4CHRNB2CHRNA7CHRNB4 | |
| SCHEMBL16472351 | 0.76 | ACACB (0.39) | GPR119 | |
| SCHEMBL17972943 | 0.76 | TSHR (0.39) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4180432-A1 | COMPOUND HAVING BTK KINASE DEGRADING ACTIVITY, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR | Sichuan Haisco Pharmaceutical Co., Ltd. (CN) | 2023-05-17 | — | — | EP | disclosed |
| WO-2022007824-A1 | COMPOUND HAVING BTK KINASE DEGRADING ACTIVITY, AND PREPARATION METHOD AND PHARMACEUTICAL USE THEREFOR | 四川海思科制药有限公司 | 2022-01-13 | — | — | WO | disclosed |